My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NovoCure Limited - Ordinary Shares (NQ:NVCR)

11.36 -0.03 (-0.26%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

October 07, 2024

Via Benzinga

Why NovoCure Stock Dived by 13% This Week ↗

September 06, 2024

Investors found the announced changes to the company's C-suite unsettling.

Via The Motley Fool

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 03, 2024

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss NovoCure Stock ↗

July 26, 2024

Via Benzinga

Breaking Down NovoCure: 4 Analysts Share Their Views ↗

July 02, 2024

Via Benzinga

A Closer Look at 7 Analyst Recommendations For NovoCure ↗

June 04, 2024

Via Benzinga

Chips, Glorious Chips! ↗

August 07, 2024

Someone's gotta make 'em, and someone's gotta buy 'em.

Via The Motley Fool

PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday ↗

July 30, 2024

Via Benzinga

NovoCure (NVCR) Q2 2024 Earnings Call Transcript ↗

July 25, 2024

NVCR earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q2 2024 ↗

July 25, 2024

NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Unveiling 8 Analyst Insights On NovoCure ↗

May 02, 2024

Via Benzinga

Why NovoCure Stock Soared 18.3% This Week ↗

March 30, 2024

Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.

Via The Motley Fool

Why Novocure Stock Is Jumping Today ↗

March 28, 2024

Novocure had good news mixed with some not-so-good news.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 07, 2024

Via Benzinga

Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday ↗

May 20, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 15, 2024

Via Benzinga

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025 ↗

May 14, 2024

These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet.

Via InvestorPlace

Peeling Back The Layers: Exploring NovoCure Through Analyst Insights ↗

March 27, 2024

Via Benzinga

NovoCure (NVCR) Q1 2024 Earnings Call Transcript ↗

May 03, 2024

NVCR earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

April 03, 2024

Via Benzinga

Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows ↗

March 27, 2024

Novocure's Phase 3 METIS trial results: TTFields therapy, combined with supportive care, significantly prolongs time to intracranial progression for NSCLC brain metastases patients compared to...

Via Benzinga

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday ↗

March 27, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Via Benzinga

Topics Stocks

Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment ↗

March 27, 2024

The company uses electrical fields to interrupt the rampant cellular division characteristic of cancer.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 27, 2024

Via Benzinga

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

NovoCure (NVCR) Q4 2023 Earnings Call Transcript ↗

February 22, 2024

NVCR earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday? ↗

January 18, 2024

During midday Thursday trading in New York, U.S. stocks displayed mixed performance, with the technology sector outperforming others as investors maintained a bullish outlook on artificial...

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

Earnings Scheduled For February 22, 2024 ↗

February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.